Health and Fitness Health and Fitness
Thu, October 21, 2010
[ Thu, Oct 21st 2010 ] - Market Wire
CardioNet, Inc. to Release Third Quarter 2010 Earnings Results on November 8, 2010
[ Thu, Oct 21st 2010 ] - Market Wire
Neoprobe Files Response to FDA Review Letter of RIGScana" Biologic License Application
[ Thu, Oct 21st 2010 ] - Market Wire
Emergency Medical Services to Host Conference Cal .. sults for Third Quarter Ending September 30, 2010
[ Thu, Oct 21st 2010 ] - Market Wire
Merit Medical Systems to Announce Third Quarter Results on November 4, 2010
[ Thu, Oct 21st 2010 ] - Market Wire
Apricus Biosciences to Present at the FSX Investor Conference in Phoenix, AZ on October 29, 2010
[ Thu, Oct 21st 2010 ] - Market Wire
A Significant Step Closer to Commercialization
[ Thu, Oct 21st 2010 ] - Market Wire
Health Net Supports Army Ten-Miler
[ Thu, Oct 21st 2010 ] - Market Wire
Idera Pharmaceuticals Presents Phase 1 Clinical D .. ate for the Treatment of Autoimmune Diseases, and
[ Thu, Oct 21st 2010 ] - Market Wire
IntegraMed® to Participate at Fifth Annual Singu .. h Best of The Uncovereds Conference on November 4
[ Thu, Oct 21st 2010 ] - Market Wire
Curis to Release Third Quarter 2010 Financial Results and Hold Conference Call on October 28, 2010
[ Thu, Oct 21st 2010 ] - Market Wire
PerkinElmer to Hold Earnings Call on Thursday, November 4, 2010
[ Thu, Oct 21st 2010 ] - Market Wire
Cardiome Announces Suspension of Enrollment in ACT 5 Trial
[ Thu, Oct 21st 2010 ] - Market Wire
Orthovita Announces 2010 Third Quarter Product Sales
[ Thu, Oct 21st 2010 ] - Market Wire
PATIENT HOME MONITORING ANNOUNCES THE APPOINTMENT .. ICING CARDIOLOGISTS TO SERVE AS BOARD OF ADVISORS
[ Thu, Oct 21st 2010 ] - Market Wire
Data Presentations at North American Cystic Fibro .. Highlight Denufosola?s Novel Mechanism of Action
[ Thu, Oct 21st 2010 ] - Market Wire
Laboratory Corporation of America® Holdings Announces 2010 Third Quarter Results
[ Thu, Oct 21st 2010 ] - Market Wire
BioCryst to Present New Clinical & Virologic Data .. or I.V. Peramivir at the 48th Annual IDSA Meeting
[ Thu, Oct 21st 2010 ] - Market Wire
Alexion Reports Third Quarter 2010 Results
[ Thu, Oct 21st 2010 ] - Market Wire
ImmunoGen, Inc. Announces Conference Call to Disc .. First Quarter Fiscal Year 2011 Financial Results
[ Thu, Oct 21st 2010 ] - Market Wire
AVEO Pharmaceuticals, Inc. Announces Timing for T .. 10 Financial Results, Webcast and Conference Call
[ Thu, Oct 21st 2010 ] - Market Wire
Icon Reports Revenues of $225 Million up 2% on Prior Year (Nasdaq:ICLR) (ISIN:IE0005711209)
[ Thu, Oct 21st 2010 ] - Market Wire
Columbia Laboratories to Discuss Third Quarter 20 .. 0 Financial Results on November 4 Conference Call
Wed, October 20, 2010
[ Wed, Oct 20th 2010 ] - Market Wire
Law Office of Brodsky & Smith, LLC Announces Investigation of Cardiac Science Corporation
[ Wed, Oct 20th 2010 ] - Market Wire
DaVita Inc. Announces Signing of New $3 Billion Secured Credit Agreement
[ Wed, Oct 20th 2010 ] - Market Wire
St. Jude Medical, Inc. Commences Exchange Offer to Acquire Shares of AGA Medical Holdings, Inc.
[ Wed, Oct 20th 2010 ] - Market Wire
Celera Corporation Third Quarter 2010 Results and Conference Call Scheduled for November 3, 2010
[ Wed, Oct 20th 2010 ] - Market Wire
Vascular Solutions Acquires Snare Product Line from Radius Medical Technologies
[ Wed, Oct 20th 2010 ] - Market Wire
Vascular Solutions Announces Record Third Quarter .. sults; Net Revenue Increases 15% to $19.9 Million
[ Wed, Oct 20th 2010 ] - Market Wire
Capital Senior Living Corporation Announces Release Date for Third Quarter 2010 Financial Results
[ Wed, Oct 20th 2010 ] - Market Wire
Celldex Therapeutics to Present at the BioCentury NewsMakers in the Biotech Industry Conference

Celldex Therapeutics to Present at the BioCentury NewsMakers in the Biotech Industry Conference


Published on 2010-10-20 12:45:42 - Market Wire
  Print publication without navigation


NEEDHAM, Mass.--([ BUSINESS WIRE ])--Celldex Therapeutics, Inc. (NASDAQ: CLDX) today announced that Thomas Davis, M.D., Senior Vice President and Chief Medical Officer of Celldex Therapeutics, Inc., will present at the BioCentury NewsMakers in the Biotech Industry Conference onFriday, October 22nd, at 2:00 p.m. EDT in New York City.

A live webcast of the presentation will be available on the aPresentationsa page of the aInvestorsa section of Celldexa™s website at [ http://www.celldextherapeutics.com ] and will be archived for 30 days following the event.

About Celldex Therapeutics, Inc.

Celldex Therapeutics is the first antibody-based combination immunotherapy company. Celldex has a pipeline of drug candidates in development for the treatment of cancer and other difficult-to-treat diseases based on its antibody focused Precision Targeted Immunotherapy Platform. The PTI Platform is a complementary portfolio of monoclonal antibodies, antibody-targeted vaccines and immunomodulators used in optimal combinations to create novel disease-specific drug candidates. For more information, please visit [ http://www.celldextherapeutics.com ].

Contributing Sources